
Cingulate Inc. - Common Stock
Share · US17248W2044 · CING (XNAS)
4,50 USD
09.06.2025 19:25
Current Prices from Cingulate Inc. - Common Stock
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() NASDAQ |
CING
|
USD
|
09.06.2025 19:25
|
4,50 USD
| 4,38 USD
+2,74 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
3,93 % | 17,45 % | 10,29 % | 15,98 % | 5,88 % | -48,12 % | -99,58 % |
Company Profile for Cingulate Inc. - Common Stock Share
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
Company Data
Name Cingulate Inc. - Common Stock
Company Cingulate Inc.
Symbol CING
Website
https://www.cingulate.com
Primary Exchange
NASDAQ

ISIN US17248W2044
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Shane J. Schaffer Pharm.D.
Market Capitalization 15 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 1901 West 47th Place, 66205 Kansas City
IPO Date 2021-12-08
Stock Splits
Date | Split |
---|---|
09.08.2024 | 1:12 |
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | CING |
More Shares
Investors who Cingulate Inc. - Common Stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.